What is the primary purpose of implantable contact lenses (IPCLs) as described in the article?

Implantable contact lenses (IPCLs) are a treatment method designed to correct myopia and astigmatism by inserting a small lens into the eye.

What material is primarily used in the construction of IPCLs, and where else is this material commonly found?

IPCLs primarily use an acrylic polymer material composed of HEMA, which is also widely used in intraocular lenses for cataracts and standard contact lenses.

How does the reversibility of IPCL treatment compare to LASIK, according to the provided information?

Unlike LASIK, which involves shaving the cornea, IPCL is a highly reversible treatment because the implanted lens can be removed in the future if necessary.

When did IPCLs receive pharmaceutical approval in Japan and when were they launched?

IPCLs obtained pharmaceutical approval from the Ministry of Health, Labour and Welfare in April 2025 and were subsequently launched in September of the same year.

What percentage of survey respondents were aware of implantable contact lenses as a treatment method?

More than 70% of the survey respondents, specifically 72.8%, indicated that they were aware of implantable contact lenses as a treatment method.

AI News NQ Analysis

Awareness Survey Conducted on Implantable Contact Lenses (Phakic Posterior Chamber Lenses) Among Men and Women in Their 20s to 40s with Visual Acuity of 0.1 or Lower

NQ Score 56/100

Key facts

Awareness Survey Conducted on Implantable Contact Lenses (Phakic Posterior Chamber Lenses) Among Men and Women in Their 20s to 40s with Visual Acuity of 0.1 or Lower
AtWorking Co., Ltd. conducted an awareness survey on implantable contact lenses among people in their 20s to 40s with low vision. The results showed that over 70% of respondents are aware of the treatment, with high interest driven by the inconvenience and cost of traditional vision correction, though concerns about surgery and safety remain.
Date: Mon Mar 30 2026 05:11:11 GMT+0900 (Japan Standard Time)

Direct answer

AtWorking Co., Ltd. conducted an awareness survey on implantable contact lenses among people in their 20s to 40s with low vision. The results showed that over 70% of respondents are aware of the treatment, with high interest driven by the inconvenience and cost of traditional vision correction, though concerns about surgery and safety remain.

Citation: Awareness Survey Conducted on Implantable Contact Lenses (Phakic Posterior Chamber Lenses) Among Men and Women in Their 20s to 40s with Visual Acuity of 0.1 or Lower (Mon Mar 30 2026 05:11:11 GMT+0900 (Japan Standard Time)), PR TIMES
Source: PR TIMES
Date: Mon Mar 30 2026 05:11:11 GMT+0900 (Japan Standard Time)

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the primary purpose of implantable contact lenses (IPCLs) as described in the article?: A: Implantable contact lenses (IPCLs) are a treatment method designed to correct myopia and astigmatism by inserting a small lens into the eye.
Q: What material is primarily used in the construction of IPCLs, and where else is this material commonly found?: A: IPCLs primarily use an acrylic polymer material composed of HEMA, which is also widely used in intraocular lenses for cataracts and standard contact lenses.
Q: How does the reversibility of IPCL treatment compare to LASIK, according to the provided information?: A: Unlike LASIK, which involves shaving the cornea, IPCL is a highly reversible treatment because the implanted lens can be removed in the future if necessary.
Q: When did IPCLs receive pharmaceutical approval in Japan and when were they launched?: A: IPCLs obtained pharmaceutical approval from the Ministry of Health, Labour and Welfare in April 2025 and were subsequently launched in September of the same year.
Q: What percentage of survey respondents were aware of implantable contact lenses as a treatment method?: A: More than 70% of the survey respondents, specifically 72.8%, indicated that they were aware of implantable contact lenses as a treatment method.